Targeting and Internalization Mechanism of LFA-1
Targeting and Internalization Mechanism of LFA-1
批准号:
7082012
负责人:
TERUNA J. SIAHAAN
金额:
$27.8万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-01 至 2009-03-31
关键词:
antiarthritic agentapoptosisbinding proteinscell adhesion moleculescrosslinkcytokinecytotoxicitydosageendocytosisfolatehelper T lymphocyteimmunoconjugateslaboratory mouseleukocyte activation /transformationleukocyte adhesion moleculesmethotrexateprotein protein interactionreceptor mediated endocytosistissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long-term objective of this proposal is to understand the mechanism of internalization of integrins and their utility for targeting drugs to specific cells. The short-term objective of this proposal is to study the mechanism of internalization of LFA-1 on T cells and to utilize this mechanism for targeting drugs to leukocytes. The central hypothesis is that an ICAM-1-derived peptide (cIBR) can bind to and be internalized by LFA-1. Therefore, a cytotoxic drug (methotrexate, MTX) will be linked with cIBR peptide to give MTX-cIBR conjugate; this conjugate will have dual functions: (a) to inhibit T-cell activation via inhibition of the cell adhesion signal and (b) to induce T-cell death by internalizing MTX. The MTX-cIBR conjugate has selective toxicity for LFA-1-expressing T cells but not LFA-1-deficient KB epithelial cells. MTXcIBR conjugate suppressed rheumatoid arthritis in the collagen-induced arthritis (CIA) mouse model better than MTX alone. Therefore, the first objective is to evaluate the mechanism of suppression of arthritis by MTX-cIBR conjugate (Specific Aim 1). The mechanism of MTX-cIBR conjugate in altering the activation of T cells from Th1 to Th2 response in the CIA mouse model will be elucidated. In addition, the long-term kinetic effects of MTX-cIBR on the T-cell commitment in the CIA mouse model will be determined. Secondly, the internalization of MTX-cIBR or FITC-cIBR conjugates will be released by LFA-1 in the cytoplasm; alternatively, it could (a) remain with the endosome, (b) be recycled to the cell surface, or (c) be targeted to other membrane compartments. Therefore, the internalization process and localization of these conjugates will be determined (Specific Aim 2). Thirdly, the internalization of MTX-cIBR may also be via reduced folate carrier (RFC) or membrane folate binding protein (mFBP). In Specific Aim 3, MTX-cIBR will be compared using wild type and RFC-deficient mouse leukemia T cells. In addition, this conjugate will be compared with MTX in mFBP over-expressing leukemia mouse cells in the presence and absence of folic acid. Finally, the exact mechanism of the LFA-1 internalization and the identity of other proteins that are involved in this process are not well understood. In Specific Aim 4, cIBR peptide will be modified and cross-linked to LFA-1 on activated T cells; the crosslink will be isolated along with proteins that interact with LFA-1. These isolated proteins will be identified.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Reshaping ApoE4 and Alzheimer's Brains with ApoE2
-
批准号:10549826
-
项目类别:
-
资助金额:$58.55万
-
财政年份:2022
-
负责人:TERUNA J. SIAHAAN
-
依托单位:
Reshaping ApoE4 and Alzheimer's Brains with ApoE2
-
批准号:10363417
-
项目类别:
-
资助金额:$58.09万
-
财政年份:2022
-
负责人:TERUNA J. SIAHAAN
-
依托单位:
Reshaping ApoE4 and Alzheimer's Brains with ApoE2
-
批准号:10812094
-
项目类别:
-
资助金额:$16.82万
-
财政年份:2022
-
负责人:TERUNA J. SIAHAAN
-
依托单位:
Modulating the BBB to Improve Drug Delivery to the Brain
-
批准号:8320154
-
项目类别:
-
资助金额:$30.56万
-
财政年份:2011
-
负责人:TERUNA J. SIAHAAN
-
依托单位:
Modulating the BBB to Improve Drug Delivery to the Brain
-
批准号:8492187
-
项目类别:
-
资助金额:$27.8万
-
财政年份:2011
-
负责人:TERUNA J. SIAHAAN
-
依托单位:
Modulating the BBB to Improve Drug Delivery to the Brain
-
批准号:8162174
-
项目类别:
-
资助金额:$32.66万
-
财政年份:2011
-
负责人:TERUNA J. SIAHAAN
-
依托单位:
Modulating the BBB to Improve Drug Delivery to the Brain
-
批准号:8666676
-
项目类别:
-
资助金额:$30.16万
-
财政年份:2011
-
负责人:TERUNA J. SIAHAAN
-
依托单位:
Targeting and Internalization Mechanism of LFA-1
-
批准号:6968983
-
项目类别:
-
资助金额:$23.84万
-
财政年份:2005
-
负责人:TERUNA J. SIAHAAN
-
依托单位:
Targeting and Internalization Mechanism of LFA-1
-
批准号:7209818
-
项目类别:
-
资助金额:$26.98万
-
财政年份:2005
-
负责人:TERUNA J. SIAHAAN
-
依托单位:
Tergeting LFA-1 for Delivering Antigenic Peptides
-
批准号:8086072
-
项目类别:
-
资助金额:$35.79万
-
财政年份:2005
-
负责人:TERUNA J. SIAHAAN
-
依托单位:
Targeting and Internalization Mechanism of LFA-1
-
批准号:7387425
-
项目类别:
-
资助金额:$26.46万
-
财政年份:2005
-
负责人:TERUNA J. SIAHAAN
-
依托单位:
Modulation of the Intercellular Junction Cadherins
-
批准号:6682854
-
项目类别:
-
资助金额:$22.92万
-
财政年份:2001
-
负责人:TERUNA J. SIAHAAN
-
依托单位:
Modulation of the Intercellular Junction Cadherins
-
批准号:6370424
-
项目类别:
-
资助金额:$22.47万
-
财政年份:2001
-
负责人:TERUNA J. SIAHAAN
-
依托单位:
Modulation of the Intercellular Junction Cadherins
-
批准号:6514472
-
项目类别:
-
资助金额:$22.26万
-
财政年份:2001
-
负责人:TERUNA J. SIAHAAN
-
依托单位:
Modulation of the Intercellular Junction Cadherins
-
批准号:6750054
-
项目类别:
-
资助金额:$22.92万
-
财政年份:2001
-
负责人:TERUNA J. SIAHAAN
-
依托单位:
IMPROVING BIOAVAILABILITY OF RGD PEPTIDOMIMETICS
-
批准号:2563433
-
项目类别:
-
资助金额:$26.72万
-
财政年份:1998
-
负责人:TERUNA J. SIAHAAN
-
依托单位:
IMPROVING BIOAVAILABILITY OF RGD PEPTIDOMIMETICS
-
批准号:6183955
-
项目类别:
-
资助金额:$25.63万
-
财政年份:1998
-
负责人:TERUNA J. SIAHAAN
-
依托单位:
IMPROVING BIOAVAILABILITY OF RGD PEPTIDOMIMETICS
-
批准号:2910666
-
项目类别:
-
资助金额:$26.42万
-
财政年份:1998
-
负责人:TERUNA J. SIAHAAN
-
依托单位:
Pharmaceutical Aspects of Biotechnology Training
-
批准号:8494626
-
项目类别:
-
资助金额:$30.66万
-
财政年份:1989
-
负责人:TERUNA J. SIAHAAN
-
依托单位:
Pharmaceutical Aspects of Biotechnology
-
批准号:8742968
-
项目类别:
-
资助金额:$33.84万
-
财政年份:1989
-
负责人:TERUNA J. SIAHAAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: